Skip to main content
Premium Trial:

Request an Annual Quote

Bar Harbor Biotech Closes 'Multi-Million-Dollar' VC Round; Plans Oct. 1 Product Launch

NEW YORK (GenomeWeb News) — Bar Harbor Biotechnology has closed a “multi-million dollar” round of Series A financing and plans to use the cash to market its first product, the company said Tuesday.
Bar Harbor Biotechnology, based in Trenton, Maine, is developing a suite of gene-expression products that includes bioanalysis software, qPCR arrays, and bioinformatics applications for gene-expression experiments.
Bar Harbor, which spun off from the Jackson Laboratory in 2006, said it plans to launch its first commercial product on Oct. 1. It was not immediately clear what that product will be.
Leading the investment round was Borealis Ventures, a seed capital company based in Hanover, NH, that focuses on New England startups. Village Ventures, an early-stage investment specialist based in Williamstown, Mass., contributed to the round.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.